Enrofloxacin,Ciprofloxacin Antikörper

Produktnummer ABIN111400

Dieser Maus Monoklonal Antikörper detektiert spezifisch Enrofloxacin,Ciprofloxacin in EIA. Es zeigt Reaktivität gegenüber Proben von Campylobacter.

Kurzübersicht für Enrofloxacin,Ciprofloxacin Antikörper (ABIN111400)

Target: Enrofloxacin,Ciprofloxacin

Reaktivität: Campylobacter

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: Enzyme Immunoassay (EIA)

Klon: 72FIG1F7#1

Produktdetails

Aufreinigung: Purified

Immunogen: Enrofloxacin conjugated to KLH (keyhole limpet hemocyanin) via carbodiimide

Isotyp: IgM

Anwendungsinformationen

Applikationshinweise: Suitable for use in ELISA.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL (OD280 nm)

Buffer: PBS buffer, pH 7.4 without preservatives

Konservierungsmittel: Without preservative

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Antigendetails

Target: Enrofloxacin,Ciprofloxacin

Hintergrund: Enrofloxacin is a fluoroquinolone that inhibits the activity of bacterial DNA gyrase. It was the first fluoroquinolone antimicrobial to be used in veterinary infections by E. coli, Salmonella, Pasteurella, Mycoplasma and Hemophilus species. Ciprofloxacin, a fluoroquinolone, is a concentration dependent bactericidal agent. It is structurally related to enrofloxacin, and has a similar spectrum of activity. Both of these antimicrobials have shown activity against some gram positive aerobes and a wide range of gram negative bacilli and cocci, which include Klebsiella, Pseudomonas, Salmonella, and other organisms such as Mycoplasma, Staphylococci and Chlamydia. Due to the fluoroquinolone's variable activity against most Streptococci, as well as their weak activity against many anaerobic bacteria, they are generally not recommended for use in treating infections where these types of microbes are present. Like enrofloxacin, ciprofloxacin is believed to act by inhibiting bacterial DNA gyrase which prevents DNA supercoiling and DNA synthesis.